[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

ARQT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 20.70%

Insider Buying (Last 12 Months): $200,000.00

Insider Selling (Last 12 Months): $787,385.46

Arcutis Biotherapeutics Insider Trading History Chart

Arcutis Biotherapeutics Share Price & Price History

^$2.16

▼ -0.04 (-1.82%)

As of 12/8/2023 01:00 AM ET

Days: 30 | 90 | 365

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

Arcutis Biotherapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/21/2023	Masaru Matsuda	Insider	Sell	1,850	$1.98	$3,663.00	46,634
10/24/2023	Life Sciences Viii L Frazier	Major Shareholder	Buy	80,000	$2.50	$200,000.00	8,764,232
8/21/2023	Patrick Burnett	Insider	Sell	1,605	$7.04	$11,299.20	58,357
5/31/2023	Masaru Matsuda	Insider	Sell	1,830	$7.80	$14,274.00	42,146
4/17/2023	Howard G. Welgus	Director	Sell	8,500	$13.97	$118,745.00	165,825
4/6/2023	Howard G. Welgus	Director	Sell	8,500	$12.01	$102,085.00	165,825
3/6/2023	Patricia A. Turney	SVP	Sell	831	$15.26	$12,681.06	62,862
3/6/2023	Scott L. Burrows	CFO	Sell	291	$15.26	$4,440.66	59,115
3/6/2023	Todd Franklin Watanabe	Insider	Sell	2,435	$15.26	$37,158.10	366,657
3/2/2023	Patricia A. Turney	SVP	Sell	1,432	$15.83	$22,668.56	45,693
3/2/2023	Scott L. Burrows	CFO	Sell	1,434	$15.83	$22,700.22	38,406
3/2/2023	Todd Franklin Watanabe	Insider	Sell	5,472	$15.83	$86,621.76	369,092
2/28/2023	Patricia A. Turney	SVP	Sell	936	$16.17	$15,135.12	47,125
2/28/2023	Scott L. Burrows	CFO	Sell	416	$16.17	$6,726.72	39,840
2/28/2023	Todd Franklin Watanabe	Insider	Sell	2,343	$16.17	$37,886.31	374,564
2/15/2023	Howard G. Welgus	Director	Sell	8,500	$16.98	$144,330.00	165,825
2/13/2023	Todd Franklin Watanabe	Insider	Sell	483	$17.00	$8,211.00	377,424
1/17/2023	Howard G. Welgus	Director	Sell	8,500	$13.72	$116,620.00	165,825
1/3/2023	Patrick Burnett	Insider	Sell	1,475	$15.01	$22,139.75	41,564
12/7/2022	Todd Franklin Watanabe	Insider	Sell	1,000	$17.06	$17,060.00	378,907
11/21/2022	Masaru Matsuda	Insider	Sell	1,720	$18.19	$31,286.80	19,535
11/7/2022	Todd Franklin Watanabe	Insider	Sell	1,000	$18.00	$18,000.00	379,907
10/7/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$19.51	$19,510.00	380,907
10/4/2022	Howard G. Welgus	Director	Sell	6,000	$20.29	$121,740.00	168,208
9/7/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$21.51	$21,510.00	381,907
8/15/2022	Howard G. Welgus	Director	Sell	6,000	$24.80	$148,800.00	174,208
7/18/2022	Howard G. Welgus	Director	Sell	6,000	$24.40	$146,400.00	180,208
7/8/2022	David W Osborne	Insider	Sell	2,197	$25.41	$55,825.77	256,649
7/8/2022	Todd Franklin Watanabe	CEO	Sell	13,500	$25.37	$342,495.00	651,871
7/6/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$22.07	$22,070.00	658,284
6/24/2022	Orbimed Advisors Llc	Major Shareholder	Sell	341,971	$21.31	$7,287,402.01	415,142
6/2/2022	Masaru Matsuda	SVP	Sell	1,795	$19.73	$35,415.35	16,380
6/1/2022	Howard G. Welgus	Director	Sell	2,500	$20.62	$51,550.00	181,896
5/5/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$21.76	$21,760.00	658,667
5/2/2022	Howard G. Welgus	Director	Sell	2,500	$20.44	$51,100.00	181,896
4/21/2022	David W Osborne	Insider	Sell	2,197	$20.42	$44,862.74	257,229
4/8/2022	Orbimed Advisors Llc	Major Shareholder	Sell	200,000	$20.71	$4,142,000.00
4/6/2022	Orbimed Advisors Llc	Major Shareholder	Sell	333,204	$20.69	$6,893,990.76
4/5/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$21.43	$21,430.00	659,667
4/1/2022	Howard G. Welgus	Director	Sell	7,500	$20.02	$150,150.00
3/9/2022	Todd Franklin Watanabe	CEO	Sell	300	$17.00	$5,100.00
3/7/2022	Patrick Burnett	Insider	Sell	30	$16.44	$493.20
3/7/2022	Scott L. Burrows	CFO	Sell	10	$16.44	$164.40
3/7/2022	Todd Franklin Watanabe	CEO	Sell	770	$17.05	$13,128.50
3/4/2022	Patricia A. Turney	SVP	Sell	993	$16.86	$16,741.98
3/4/2022	Patrick Burnett	Insider	Sell	981	$16.86	$16,539.66
3/4/2022	Scott L. Burrows	CFO	Sell	293	$16.86	$4,939.98
3/4/2022	Todd Franklin Watanabe	CEO	Sell	2,489	$16.86	$41,964.54
2/9/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$17.00	$17,000.00
1/5/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$21.59	$21,590.00
1/3/2022	Howard G. Welgus	Director	Sell	2,500	$21.21	$53,025.00
12/27/2021	Scott L. Burrows	CFO	Sell	12,560	$20.07	$252,079.20
12/23/2021	Howard G. Welgus	Director	Sell	2,500	$20.16	$50,400.00
12/8/2021	Todd Franklin Watanabe	CEO	Sell	1,000	$17.00	$17,000.00
11/5/2021	Todd Franklin Watanabe	CEO	Sell	1,000	$21.50	$21,500.00
11/1/2021	Howard G. Welgus	Director	Sell	2,500	$21.81	$54,525.00
10/5/2021	Todd Franklin Watanabe	CEO	Sell	2,500	$24.92	$62,300.00
9/7/2021	Todd Franklin Watanabe	CEO	Sell	1,000	$21.14	$21,140.00
8/5/2021	Todd Franklin Watanabe	CEO	Sell	1,000	$20.81	$20,810.00
7/6/2021	Todd Franklin Watanabe	CEO	Sell	1,750	$26.58	$46,515.00
7/1/2021	Howard G. Welgus	Director	Sell	2,200	$26.13	$57,486.00
6/24/2021	Bhaskar Chaudhuri	Director	Sell	729	$27.50	$20,047.50	848,146
6/21/2021	Bhaskar Chaudhuri	Director	Sell	2,516	$27.50	$69,190.00	848,875
6/7/2021	Todd Franklin Watanabe	CEO	Sell	1,750	$26.35	$46,112.50
5/7/2021	Todd Franklin Watanabe	CEO	Sell	750	$35.00	$26,250.00
5/5/2021	Todd Franklin Watanabe	CEO	Sell	1,750	$34.00	$59,500.00
4/20/2021	Bhaskar Chaudhuri	Director	Sell	10,000	$28.06	$280,600.00	862,671
4/5/2021	Todd Franklin Watanabe	CEO	Sell	1,750	$29.93	$52,377.50
4/1/2021	Howard G. Welgus	Director	Sell	2,200	$29.49	$64,878.00
3/22/2021	Bhaskar Chaudhuri	Director	Sell	10,000	$31.10	$311,000.00	876,383
3/5/2021	Todd Franklin Watanabe	CEO	Sell	1,750	$30.55	$53,462.50
2/10/2021	John W. Smither	CFO	Sell	750	$35.64	$26,730.00
2/1/2021	Bhaskar Chaudhuri	Director	Sell	9,949	$33.25	$330,804.25	901,340
2/1/2021	John W. Smither	CFO	Sell	1,250	$35.00	$43,750.00
1/29/2021	Bhaskar Chaudhuri	Director	Sell	51	$27.50	$1,402.50	901,340
1/19/2021	John W. Smither	CFO	Sell	500	$30.00	$15,000.00

New CBOE “special perk” helps traders target income every weekend

From DTI Trader | Ad

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

Check out this training for the full story!

SEC Filings (Institutional Ownership Changes) for Arcutis Biotherapeutics (NASDAQ:ARQT)

Institutional Buying and Selling by Quarter

Arcutis Biotherapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/6/2023	Citigroup Inc.	176,822	$0.94M	0.0%	+15.1%	0.187%
11/22/2023	Polar Capital Holdings Plc	3,117,944	$16.56M	0.1%	-0.3%	3.304%
11/16/2023	Tudor Investment Corp Et Al	45,461	$0.24M	0.0%	N/A	0.048%
11/15/2023	Tejara Capital Ltd	309,179	$1.64M	0.9%	+88.3%	0.328%
11/15/2023	Rubric Capital Management LP	5,034,530	$26.73M	1.0%	+3.1%	5.334%
11/15/2023	Schroder Investment Management Group	11,398	$64K	0.0%	N/A	0.012%
11/15/2023	Legal & General Group Plc	43,763	$0.23M	0.0%	+20.9%	0.046%
11/14/2023	Rubric Capital Management LP	5,034,530	$26.73M	1.0%	+3.1%	5.334%
11/14/2023	Trexquant Investment LP	58,568	$0.31M	0.0%	N/A	0.062%
11/14/2023	Profund Advisors LLC	69,926	$0.37M	0.0%	-22.1%	0.074%
11/13/2023	Fishman Jay A Ltd. MI	87,000	$0.46M	0.1%	+13.0%	0.092%
11/13/2023	Northern Trust Corp	483,499	$2.57M	0.0%	+3.8%	0.512%
11/13/2023	Federated Hermes Inc.	60,000	$0.32M	0.0%	+50.0%	0.064%
11/13/2023	LPL Financial LLC	83,513	$0.44M	0.0%	+141.5%	0.088%
11/13/2023	Dark Forest Capital Management LP	74,293	$0.39M	0.0%	N/A	0.079%
11/13/2023	FMR LLC	8,262,042	$43.87M	0.0%	-10.3%	8.754%
11/13/2023	Tejara Capital Ltd	309,179	$1.64M	1.2%	+88.3%	0.328%
11/13/2023	Rafferty Asset Management LLC	419,309	$2.23M	0.0%	-16.1%	0.444%
11/13/2023	E Fund Management Co. Ltd.	21,535	$0.11M	0.0%	-19.9%	0.023%
11/9/2023	Citigroup Inc.	176,822	$0.94M	0.0%	+15.1%	0.287%
11/9/2023	UBS Group AG	64,142	$0.34M	0.0%	-54.1%	0.104%
11/8/2023	Wade G W & Inc.	39,400	$0.21M	0.0%	+168.0%	0.064%
11/8/2023	Charles Schwab Investment Management Inc.	383,813	$2.04M	0.0%	+16.3%	0.623%
11/8/2023	Swiss National Bank	101,200	$0.54M	0.0%	+9.9%	0.164%
11/7/2023	Barclays PLC	207,077	$1.10M	0.0%	-11.3%	0.336%
11/7/2023	Fox Run Management L.L.C.	11,216	$60K	0.0%	N/A	0.018%
11/7/2023	Jump Financial LLC	20,286	$0.11M	0.0%	N/A	0.033%
10/31/2023	Jennison Associates LLC	4,432,175	$23.54M	0.0%	+3.2%	7.189%
10/27/2023	Hennion & Walsh Asset Management Inc.	95,308	$0.51M	0.0%	-6.9%	0.155%
10/24/2023	Bank of New York Mellon Corp	237,779	$1.26M	0.0%	+12.9%	0.386%
10/11/2023	Vontobel Holding Ltd.	49,191	$0.26M	0.0%	+75.3%	0.080%
9/21/2023	Barclays PLC	233,418	$2.22M	0.0%	-82.5%	0.379%
8/21/2023	California State Teachers Retirement System	54,715	$0.52M	0.0%	+3.4%	0.089%
8/16/2023	Nuveen Asset Management LLC	212,696	$2.03M	0.0%	+105.0%	0.345%
8/15/2023	Alliancebernstein L.P.	80,030	$0.76M	0.0%	-46.1%	0.130%
8/15/2023	Wells Fargo & Company MN	106,750	$1.02M	0.0%	+70.4%	0.173%
8/15/2023	Fishman Jay A Ltd. MI	77,000	$0.73M	0.1%	+20.7%	0.125%
8/15/2023	Woodline Partners LP	807,750	$7.70M	0.1%	+16.1%	1.310%
8/15/2023	Goldman Sachs Group Inc.	694,321	$6.62M	0.0%	+181.1%	1.126%
8/15/2023	Suvretta Capital Management LLC	872,427	$8.31M	0.4%	+28.4%	1.415%
8/15/2023	Holocene Advisors LP	1,440,036	$13.72M	0.1%	-30.4%	2.336%
8/15/2023	Cantor Fitzgerald L. P.	56,903	$0.54M	0.0%	N/A	0.092%
8/14/2023	PDT Partners LLC	120,578	$1.15M	0.2%	-22.4%	0.196%
8/14/2023	Cormorant Asset Management LP	800,000	$7.62M	0.4%	N/A	1.298%
8/14/2023	Tower Research Capital LLC TRC	11,991	$0.11M	0.0%	+357.0%	0.019%
8/14/2023	Marshall Wace LLP	2,317,541	$22.09M	0.0%	+0.5%	3.759%
8/14/2023	State of Wisconsin Investment Board	37,370	$0.36M	0.0%	-5.1%	0.061%
8/14/2023	State Street Corp	5,226,009	$49.80M	0.0%	+44.6%	8.477%
8/14/2023	UniSuper Management Pty Ltd	340,000	$3.24M	0.0%	N/A	0.552%
8/14/2023	Nuveen Asset Management LLC	212,696	$2.03M	0.0%	+105.0%	0.345%
8/14/2023	Polar Capital Holdings Plc	3,127,777	$29.81M	0.2%	-0.2%	5.073%
8/11/2023	Pivotal bioVenture Partners Investment Advisor LLC	1,105,309	$10.53M	3.5%	+94.2%	1.793%
8/11/2023	Credit Suisse AG	78,272	$0.75M	0.0%	+120.5%	0.127%
8/11/2023	BlackRock Inc.	4,231,374	$40.33M	0.0%	-8.0%	6.864%
8/11/2023	Sectoral Asset Management Inc.	14,287	$0.14M	0.0%	-95.5%	0.023%
8/11/2023	Rubric Capital Management LP	4,884,530	$46.55M	2.0%	+39.6%	7.923%
8/11/2023	The Manufacturers Life Insurance Company	21,042	$0.20M	0.0%	+28.4%	0.034%
8/11/2023	Hsbc Holdings PLC	144,815	$1.38M	0.0%	+19.2%	0.235%
8/11/2023	Franklin Resources Inc.	1,652,536	$15.75M	0.0%	+3.7%	2.681%
8/11/2023	Geode Capital Management LLC	937,447	$8.93M	0.0%	+16.0%	1.521%
8/11/2023	Tejara Capital Ltd	164,179	$1.57M	0.8%	+67.5%	0.266%
8/11/2023	E Fund Management Co. Ltd.	26,877	$0.26M	0.0%	+55.4%	0.044%
8/11/2023	JPMorgan Chase & Co.	71,008	$0.68M	0.0%	+29.0%	0.115%
8/11/2023	PNC Financial Services Group Inc.	9,815	$94K	0.0%	+19.4%	0.016%
8/11/2023	Northern Trust Corp	465,653	$4.44M	0.0%	+20.4%	0.755%
8/10/2023	MetLife Investment Management LLC	27,203	$0.26M	0.0%	+25.1%	0.044%
8/10/2023	ProShare Advisors LLC	10,661	$0.10M	0.0%	N/A	0.017%
8/10/2023	Profund Advisors LLC	89,780	$0.86M	0.0%	+59.8%	0.146%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	37,417	$0.34M	0.0%	+17.0%	0.061%
8/10/2023	Charles Schwab Investment Management Inc.	329,942	$3.14M	0.0%	+9.1%	0.537%
8/10/2023	Citigroup Inc.	153,588	$1.46M	0.0%	-37.1%	0.250%
8/9/2023	Dimensional Fund Advisors LP	142,599	$1.36M	0.0%	-67.5%	0.232%
8/8/2023	Rhumbline Advisers	78,552	$0.75M	0.0%	+45.0%	0.128%
8/8/2023	AlphaCentric Advisors LLC	292,500	$2.79M	1.5%	+53.9%	0.476%
8/8/2023	Commerce Bank	19,005	$0.18M	0.0%	+14.0%	0.031%
8/7/2023	Principal Financial Group Inc.	14,936	$0.14M	0.0%	+11.6%	0.024%
8/4/2023	American International Group Inc.	24,748	$0.24M	0.0%	+23.5%	0.040%
8/3/2023	Barclays PLC	233,418	$2.22M	0.0%	-82.5%	0.380%
8/3/2023	Jennison Associates LLC	4,293,966	$40.92M	0.0%	+93.9%	6.991%
8/3/2023	Bank of New York Mellon Corp	210,609	$2.01M	0.0%	+54.7%	0.343%
8/1/2023	Regency Capital Management Inc. DE	13,000	$0.12M	0.1%	N/A	0.021%
8/1/2023	Keybank National Association OH	13,029	$0.12M	0.0%	N/A	0.021%
7/31/2023	LPL Financial LLC	34,582	$0.33M	0.0%	N/A	0.056%
7/27/2023	Virtu Financial LLC	21,769	$0.21M	0.0%	N/A	0.035%
7/24/2023	Vontobel Holding Ltd.	28,066	$0.27M	0.0%	+23.3%	0.046%
7/19/2023	Teacher Retirement System of Texas	11,600	$0.11M	0.0%	-11.7%	0.019%
7/10/2023	SG Americas Securities LLC	28,414	$0.27M	0.0%	+11.5%	0.046%
6/1/2023	Prelude Capital Management LLC	14,648	$0.16M	0.0%	N/A	0.024%
5/22/2023	Ameriprise Financial Inc.	854,734	$9.40M	0.0%	+5.1%	1.392%
5/18/2023	JPMorgan Chase & Co.	55,039	$0.61M	0.0%	+23.4%	0.090%
5/18/2023	New York State Common Retirement Fund	23,966	$0.26M	0.0%	-20.0%	0.039%
5/16/2023	Jane Street Group LLC	26,255	$0.29M	0.0%	N/A	0.043%
5/16/2023	State Street Corp	3,614,781	$39.76M	0.0%	-1.8%	5.885%
5/16/2023	Saturn V Capital Management LLC	178,217	$1.96M	1.5%	-63.4%	0.290%
5/16/2023	Geode Capital Management LLC	808,367	$8.89M	0.0%	+3.8%	1.317%
5/16/2023	Balyasny Asset Management L.P.	44,288	$0.49M	0.0%	N/A	0.072%
5/15/2023	Suvretta Capital Management LLC	679,391	$7.47M	0.3%	N/A	1.107%
5/15/2023	Two Sigma Advisers LP	16,000	$0.18M	0.0%	-88.2%	0.026%
5/15/2023	Deutsche Bank AG	36,293	$0.40M	0.0%	+44.2%	0.059%
5/15/2023	Ensign Peak Advisors Inc	486,240	$5.35M	0.0%	+0.3%	0.792%

Data available starting January 2016

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical formulation of ivarmacitinib designed to reach deeper into the skin in order to treat alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Today's Range

Now: $2.16

$2.12

$2.22

50 Day Range

MA: $2.72

$1.84

$4.82

52 Week Range

Now: $2.16

$1.76

$18.04

Volume

1,984,199 shs

Average Volume

2,730,491 shs

Market Capitalization

$203.87 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.76

Who are the company insiders with the largest holdings of Arcutis Biotherapeutics?: Arcutis Biotherapeutics' top insider shareholders include:
Life Sciences Viii L Frazier (Major Shareholder)
Todd Franklin Watanabe (CEO)
Orbimed Advisors Llc (Major Shareholder)
Todd Franklin Watanabe (Insider)
David W Osborne (Insider)
Howard G Welgus (Director)
Patricia A Turney (SVP)
Scott L Burrows (CFO)
Patrick Burnett (Insider)
Masaru Matsuda (Insider)
Masaru Matsuda (SVP)
Learn More about top insider investors at Arcutis Biotherapeutics.
Who are the major institutional investors of Arcutis Biotherapeutics?: Arcutis Biotherapeutics' top institutional shareholders include:
FMR LLC — 8.75%
Rubric Capital Management LP — 5.33%
Rubric Capital Management LP — 5.33%
Jennison Associates LLC — 7.19%
Polar Capital Holdings Plc — 3.30%
Northern Trust Corp — 0.51%
Learn More about top institutional investors of Arcutis Biotherapeutics stock.
Which institutional investors are selling Arcutis Biotherapeutics stock?: During the previous quarter, ARQT stock was sold by these institutional investors:
FMR LLC
Rafferty Asset Management LLC
UBS Group AG
Barclays PLC
Profund Advisors LLC
Group One Trading L.P.
Polar Capital Holdings Plc
Hennion & Walsh Asset Management Inc.
In the last year, company insiders that have sold Arcutis Biotherapeutics company stock include:
Life Sciences Viii L Frazier (Major Shareholder)
Todd Franklin Watanabe (CEO)
Orbimed Advisors Llc (Major Shareholder)
Todd Franklin Watanabe (Insider)
David W Osborne (Insider)
Howard G Welgus (Director)
Learn More investors selling Arcutis Biotherapeutics stock.
Which institutional investors are buying Arcutis Biotherapeutics stock?: During the previous quarter, ARQT stock was purchased by institutional investors including:
Rubric Capital Management LP
Rubric Capital Management LP
Tejara Capital Ltd
Tejara Capital Ltd
Jennison Associates LLC
Dark Forest Capital Management LP
Trexquant Investment LP
Charles Schwab Investment Management Inc.

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

ARQT Insider Trading

Arcutis Biotherapeutics Insider Trading History Chart

Arcutis Biotherapeutics Share Price & Price History

Arcutis Biotherapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Arcutis Biotherapeutics (NASDAQ:ARQT)

Institutional Buying and Selling by Quarter

Arcutis Biotherapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Arcutis Biotherapeutics?

Who are the major institutional investors of Arcutis Biotherapeutics?

Which institutional investors are selling Arcutis Biotherapeutics stock?

Which institutional investors are buying Arcutis Biotherapeutics stock?